Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
about
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndromePrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesThe clinical significance of antiphospholipid antibodies in systemic lupus erythematosusInfluence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy.Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.Management of the antiphospholipid syndromeAspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and SafetyAntiphospholipid syndrome and the brain in pediatric and adult patientsAspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status.Guidelines for the treatment of antiphospholipid syndrome.Cerebral embolism from Libman-Sacks endocarditis.Treatment of the antiphospholipid syndrome.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Aspirin and multiple sclerosisSeizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.The antiphospholipid syndrome: still an enigmaD-dimer level and the risk for thrombosis in systemic lupus erythematosus.Latest advances in connective tissue disorders.Controversies in the antiphospholipid syndrome: can we ever stop warfarin?Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.Lupus: improving long-term prognosis.High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study.New developments in lupus-associated antiphospholipid syndrome.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Galactorrhea associated with juvenile systemic lupus erythematosus: a review of the role of prolactinNew potential therapies for the treatment of antiphospholipid syndrome.Pharmacotherapy of systemic lupus erythematosus.Recent advances in understanding antiphospholipid syndrome.Thrombosis in systemic lupus erythematosus: risk and protection.Current management of antiphospholipid syndrome-related thrombosis.Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?To what extent can preventive treatments prevent damage from systemic lupus erythematosus?Low molecular weight heparin in obstetric care: a review of the literature.Guidelines on the investigation and management of antiphospholipid syndrome.Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease.
P2860
Q24185949-81D76067-2075-4C13-BB6E-A8D887AAF434Q24633010-02CD3926-DFAB-42F0-8513-5195221C9A72Q28072610-1B3A743A-66E9-4F23-BBBE-838F652FA332Q33377847-BE9CC95C-2BCA-4228-A4A8-1BCC199710E3Q33401365-DE381906-6FBA-475B-A219-2617E9BB6AB4Q33406588-2524560A-8DB9-4AE2-938B-9A02F8C76C5EQ33406643-D468E3F4-5AFC-4CAE-B2E2-425E4576D597Q33423034-05572958-CCFB-491E-96E7-DD4405E4647DQ33501445-CAB20663-C376-4D97-B03F-7F7239255410Q33692770-2F6B5532-F4D3-4E03-9823-357CBB834A9FQ34307502-8706FBBE-CD1C-4855-B796-5604151133DCQ34433987-5DC10E48-E7CB-45A2-8499-904C4AD5C722Q34821893-C9BC8871-E4CC-43CB-9B74-CB1C41CED52DQ35094631-334FED23-76D3-440B-9211-F7867D05918FQ35308972-D4C2D08F-06FD-472D-92EC-630148DD4D26Q35621012-1AED4C38-F4BC-4CF3-8B89-D3367D7E01F9Q35678040-23470D5F-E495-4776-91FE-6142E93AAD08Q35867162-24B7471A-A93B-42D0-8FA5-50CE214B97B7Q36009039-0F3FEBD4-90FF-4B2E-BBF1-3EFE0DC814B9Q36928593-749C3551-0A84-44DA-A59F-2EF9F7EEF8D5Q36947358-D37BCF55-D8DD-4EDF-BCEC-567D476BF5F3Q37058776-8079974A-F46F-47AF-BD1B-FD18D69EF8C3Q37076800-AC6EDD00-625C-4268-82FE-A7FF3BD57653Q37090069-3B1AA89F-1DE9-4C9D-B6C5-1F3AD9DA5C9FQ37121353-B41BBCF3-76CB-49BF-B06D-71017DCB2090Q37141852-27AD87BF-EEB0-40C1-978B-64B10956A084Q37168035-F04B1697-B6F6-48BE-81A2-83D4092D2EEFQ37251490-911F38F9-FAD8-4E94-AE58-B3829B98A460Q37405843-4ED67B4B-59EC-4998-B400-687EFD1DFAA2Q37481227-C63FDE9C-0CBC-44DD-ADD0-C4A9E7F70B53Q37510905-B8F7ECD2-004F-401E-8185-726500757859Q37577693-8595C13E-3FBB-465D-B071-4EAA738A3D4FQ37642828-BB8EF273-7736-47E0-8088-9E96CD3ECB8CQ37642830-99461C23-3EB1-4DE8-B418-6C3BD86AA3EFQ37721617-A90EC6F8-38E4-4D4A-8A83-82166B507C47Q37879597-CAE32322-AC07-4D5E-BFBB-363BE0837340Q37892215-3000AA2A-8010-4C4F-AA04-FF80D508464DQ37982121-6909D5D4-5A0F-4F14-A9FD-FCB682F0E247Q38003113-6A3CF4ED-28A8-4BF5-A915-2AB7CBE60C9BQ38016378-9F4A0E20-2A1D-4834-A972-0DC33AC149E5
P2860
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aspirin for primary thrombosis ...... antibody-positive individuals
@ast
Aspirin for primary thrombosis ...... antibody-positive individuals
@en
Aspirin for primary thrombosis ...... antibody-positive individuals
@nl
type
label
Aspirin for primary thrombosis ...... antibody-positive individuals
@ast
Aspirin for primary thrombosis ...... antibody-positive individuals
@en
Aspirin for primary thrombosis ...... antibody-positive individuals
@nl
prefLabel
Aspirin for primary thrombosis ...... antibody-positive individuals
@ast
Aspirin for primary thrombosis ...... antibody-positive individuals
@en
Aspirin for primary thrombosis ...... antibody-positive individuals
@nl
P2093
P2860
P50
P921
P356
P1476
Aspirin for primary thrombosis ...... antibody-positive individuals
@en
P2093
Aynur Unalp-Arida
Doruk Erkan
Lisa Sammaritano
Margaret Peterson
Melanie J Harrison
Veronica Vilela
Yusuf Yazici
P2860
P304
P356
10.1002/ART.22663
P407
P577
2007-07-01T00:00:00Z